Kraig Biocraft Laboratories Inc (KBLB)

[arachnodude]

Promoting trolls and attempting to denigrate firms who know what they're doing above and beyond in the IP field, really works to expose that negative propaganda you continue to endorse. It might help to actually read AND UNDERSTAND what's being read in company communications. The company hinted at these moves months ago. But, to provide the Cliffs Notes, these moves were strategic. Not damaging. The decision to discontinue certain patents and focus on obtaining formal IP registration for the BAM-1 hybrid silkworm strain in Vietnam is likely a strategic move to optimize the company’s IP portfolio, financial resources, and market focus. This approach aligns with common business practices aimed at enhancing efficiency and ensuring robust protection of the most critical innovations. Addition by subtraction. Strength through removal. Yep, "good thing KBLB retained Workman Nydegger for their expertise in obtaining patents. Another great expense..."

THE REAL KBLB WAY:





💥💥BAM💥💥